Pharma Sector Back in Bull Mode:
Why it stands out: Key pharma names cross above 200-DMA.
Insight: Biocon, CIPLA , Zydus, GLAND move past their long-term trendline.
Learning: Pharma valuations and technical upticks provide defensive growth exposure.
#WatchOutFor#FundamentalViews#PsychologyofMoney#PersonalFinance

















